Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diltiazem versus botulinum toxin injection for chronic anal fissure
IRCT20230607058408N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of diltiazem and neuronox in chronic anal fissure (CAF) (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoint: Fissure healing. Started Jul 2023; status: completed.
02
Drugs
diltiazemneuronox
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on IRCT20230607058408N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230607058408N1.